C12N 15/8695
Herpes simplex virus-based vectors
Official title: {Herpes simplex virus-based vectors}
C12N15/8695 (Herpes simplex virus-based vectors) appears on 13 US grants and 20 published applications in this corpus.
Search patents in C12N- Granted patents
- 13
- Published applications
- 20
- Assignees
- 9
- Inventors
- 26
- Latest grant
- 16 Jun 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2009 | 0 | 2 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 1 |
| 2013 | 0 | 1 |
| 2014 | 1 | 1 |
| 2015 | 2 | 0 |
| 2016 | 1 | 1 |
| 2017 | 2 | 3 |
| 2018 | 0 | 0 |
| 2019 | 1 | 2 |
| 2020 | 1 | 2 |
| 2021 | 0 | 1 |
| 2022 | 1 | 1 |
| 2023 | 1 | 2 |
| 2024 | 1 | 0 |
| 2025 | 1 | 2 |
| 2026 | 1 | 1 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Compositions and methods for the treatment of skin diseases16 Jun 2026US 12,655,447 B2Krystal Biotech, Inc.
- Syncytial oncolytic herpes simplex mutants as potent cancer therapeutics25 Nov 2025US 12,480,097 B2Research Institute At Nationwide Children's Hospital
- Oncolytic herpes simplex virus vectors expressing immune system-stimulatory molecules10 Dec 2024US 12,162,919 B2Virogin Biotech Canada Ltd
- Compositions and methods for the treatment of autosomal recessive congenital ichthyosis8 Aug 2023US 11,717,547 B2Krystal Biotech, Inc.
- Identification of mutations in herpes simplex virus envelope glycoproteins that enable or enhance vector retargeting to novel non-HSV receptors23 Aug 2022US 11,419,926 B2University of Pittsburgh—Of the Commonwealth System of Higher Education
- Hsv gene expression vector and bxb1 integrase-mediated recombination system for high-throughput cloning27 Aug 2026US 2026/0250643 A1Albert Einstein College of Medicine
- Compositions and Methods for the Treatment of Congenital Ichthyoses4 Sep 2025US 2025/0277237 A1Krystal Biotech, Inc.
- Oncolytic herpes simplex virus vectors expressing immune system-stimulatory molecules31 Jul 2025US 2025/0243252 A1Virogin Biotech Canada Ltd
- Compositions and methods for the treatment of autosomal recessive congenital ichthyosis26 Oct 2023US 2023/0338444 A1Krystal Biotech, Inc.
- Compositions and methods for the treatment of congenital ichthyoses20 Apr 2023US 2023/0118087 A1Krystal Biotech, Inc.
Most cited
By later US patents
- Identification of mutations in herpes simplex virus envelope glycoproteins that enable or enhance vector retargeting to novel non-HSV receptors16US 9,593,347 B2University of Pittsburgh—Of the Commonwealth System of Higher Education · 2017
- Compositions and methods for the treatment of autosomal recessive congenital ichthyosis12US 10,525,090 B2Krystal Biotech, Inc. · 2020
- Identification of mutations in herpes simplex virus envelope glycoproteins that enable or enhance vector retargeting to novel non-HSV receptors1US 10,328,136 B2University of Pittsburgh—Of the Commonwealth System of Higher Education · 2019
- Identification of mutations in herpes simplex virus envelope glycoproteins that enable or enhance vector retargeting to novel non-HSV receptors1US 11,419,926 B2University of Pittsburgh—Of the Commonwealth System of Higher Education · 2022
- Targeting of herpes simplex virus to specific receptors1US 8,927,251 B2The University of Chicago · 2015